BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2872871)

  • 1. Pharmacotherapy for patients with borderline personality disorder.
    Gunderson JG
    Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol.
    Serban G; Siegel S
    Am J Psychiatry; 1984 Nov; 141(11):1455-8. PubMed ID: 6388363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo.
    Soloff PH; George A; Nathan RS; Schulz PM; Ulrich RF; Perel JM
    Arch Gen Psychiatry; 1986 Jul; 43(7):691-7. PubMed ID: 3521532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tranquilizers on borderline and schizotypal patients questioned.
    Rockland LH
    Am J Psychiatry; 1985 May; 142(5):665-6. PubMed ID: 3885764
    [No Abstract]   [Full Text] [Related]  

  • 5. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo.
    Goldberg SC; Schulz SC; Schulz PM; Resnick RJ; Hamer RM; Friedel RO
    Arch Gen Psychiatry; 1986 Jul; 43(7):680-6. PubMed ID: 3521531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.
    Soloff PH; George A; Nathan S; Schulz PM; Cornelius JR; Herring J; Perel JM
    J Clin Psychopharmacol; 1989 Aug; 9(4):238-46. PubMed ID: 2768542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical effects of amitriptyline on borderline patients.
    Soloff PH; George A; Nathan RS; Schulz PM; Perel JM
    Am J Psychiatry; 1986 Dec; 143(12):1603-5. PubMed ID: 3538914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for patients with borderline personality disorder.
    Goldberg SC; Schulz SC
    Arch Gen Psychiatry; 1988 Feb; 45(2):195-6. PubMed ID: 2892479
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug treatment of the personality disorders.
    Stein G
    Br J Psychiatry; 1992 Aug; 161():167-84. PubMed ID: 1355689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, noncomparative study of amoxapine in borderline disorders.
    Jensen HV; Andersen J
    Acta Psychiatr Scand; 1989 Jan; 79(1):89-93. PubMed ID: 2648768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.
    Kutcher SP; Blackwood DH
    Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amitriptyline and haloperidol in unstable and schizotypal borderline disorders.
    Soloff PH; George A; Nathan S; Schulz PM; Ulrich RF; Perel JM
    Psychopharmacol Bull; 1986; 22(1):177-82. PubMed ID: 3523575
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychopharmacologic approaches to borderline syndromes.
    Ellison JM; Adler DA
    Compr Psychiatry; 1984; 25(3):255-62. PubMed ID: 6145542
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy of borderline disorders.
    Soloff PH
    Compr Psychiatry; 1981; 22(6):535-43. PubMed ID: 6118234
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects.
    Coccaro EF
    J Clin Psychiatry; 1998; 59 Suppl 1():30-5; discussion 36-7. PubMed ID: 9448667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The positive effect of alprazolam in the treatment of three patients with borderline personality disorder.
    Faltus FJ
    Am J Psychiatry; 1984 Jun; 141(6):802-3. PubMed ID: 6145360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacology of borderline personality disorder: a review.
    Cowdry RW
    J Clin Psychiatry; 1987 Aug; 48 Suppl():15-25. PubMed ID: 2886493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for personality disorders.
    Hori A
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):13-9. PubMed ID: 9682928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends in the pharmacotherapy of personality disorders.
    Markovitz PJ
    J Pers Disord; 2004 Feb; 18(1):90-101. PubMed ID: 15061346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic treatment in the borderline patient: advantages and techniques.
    Soloff PH
    J Clin Psychiatry; 1987 Aug; 48 Suppl():26-31. PubMed ID: 2886494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.